BioNTech SE American Depositary Share Earnings Dividend

BioNTech SE American Depositary Share’s revenue fell -58.84% since last year same period to $107.35Mn in the Q2 2026. On a quarterly growth basis, BioNTech SE American Depositary Share has generated -10.57% fall in its revenue since last 3-months.

BioNTech SE American Depositary Share’s net profit fell -115.83% since last year same period to $-834.39Mn in the Q2 2026. On a quarterly growth basis, BioNTech SE American Depositary Share has generated -54.33% fall in its net profits since last 3-months.

BioNTech SE American Depositary Share’s net profit margin fell -424.35% since last year same period to -777.27% in the Q2 2026. On a quarterly growth basis, BioNTech SE American Depositary Share has generated -72.58% fall in its net profit margins since last 3-months.

BioNTech SE American Depositary Share’s earning per share (EPS) estimates for the current quarter stand at -2.58 - a -34.38% fall from last quarter’s estimates.

BioNTech SE American Depositary Share’s earning per share (EPS) estimates for the current year stand at -2.58.

BioNTech SE American Depositary Share’s earning per share (EPS) fell -89.37% since last year same period to -3.03 in the Q2 2026. This indicates that the BioNTech SE American Depositary Share has generated -89.37% annual rate of fall in its earning per share (EPS) in the last 4 quarters.